GFACX
Price
$73.30
Change
+$0.65 (+0.89%)
Updated
Aug 21 closing price
Net Assets
342.42B
SPECX
Price
$36.81
Change
+$0.13 (+0.35%)
Updated
Aug 21 closing price
Net Assets
4.44B
Interact to see
Advertisement

GFACX vs SPECX

GFACX vs SPECX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. SPECX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and SPECX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 342B vs. SPECX (4.44B). GFACX (0.00) and SPECX (0.00) have matching dividends . GFACX was incepted earlier than SPECX: GFACX (25 years) vs SPECX (57 years). SPECX (1.53) is less costly to investors than GFACX (1.35). SPECX is a more actively managed with annual turnover of: 51.13 vs. GFACX (32.00). GFACX has a lower initial minimum investment than SPECX: GFACX (250) vs SPECX (1000). SPECX annual gain was more profitable for investors over the last year : 10.94 vs. GFACX (2.93). SPECX return over 5 years is better than : 12.71 vs. GFACX (7.51).
GFACXSPECXGFACX / SPECX
Total Expense Ratio1.351.5388%
Annual Report Gross Expense Ratio1.351.5388%
Fund Existence25 years57 years-
Gain YTD8.9157.789114%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets342B4.44B7,710%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.9310.9427%
Returns for 3 years38.51100.7138%
Returns for 5 years7.5112.7159%
Returns for 10 years77.91112.2869%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI7.010.16
+2.34%
Ultralife Corp
CLGN0.31N/A
+0.29%
CollPlant Biotechnologies Ltd
KEY21.870.02
+0.09%
KeyCorp
USLM118.89-1.25
-1.04%
United States Lime & Minerals
RGNX10.72-0.34
-3.07%
REGENXBIO